Boundless Bio Operating Margin 1970-1969 | BOLD
Current and historical operating margin for Boundless Bio (BOLD) over the last 10 years. The current operating profit margin for Boundless Bio as of December 31, 1969 is 0.00%.
| Boundless Bio Operating Margin Historical Data |
| Date |
TTM Revenue |
TTM Operating Income |
Operating Margin |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.000B |
$0.000B |
|
Boundless Bio Inc. is a clinical stage oncology company interrogating extrachromosomal DNA biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers. Boundless Bio Inc. is based in SAN DIEGO.
|
